Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer

ACS Medicinal Chemistry Letters
2012.0

Abstract

Tri- and tetracyclic nitrogen-bridgehead compounds were designed and synthesized to yield micromolar cholinesterase (ChE) inhibitors. Structure-activity relationships identified potent compounds with butyrylcholinesterase selectivity. These compounds were selected as starting points for the design and synthesis of carbamate-based (pseudo)irreversible inhibitors. Compounds with superior inhibitory activity and selectivity were obtained and kinetically characterized also with regard to the velocity of enzyme carbamoylation. Structural elements were identified and introduced that additionally showed neuroprotective properties on a hippocampal neuronal cell line (HT-22) after glutamate-induced intracellular reactive oxygen species generation. We have identified potent and selective pseudoirreversible butyrylcholinesterase inhibitors that release reversible inhibitors with neuroprotective properties after carbamate transfer to the active site of cholinesterases.

Knowledge Graph

Similar Paper

Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer
ACS Medicinal Chemistry Letters 2012.0
Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase
Bioorganic & Medicinal Chemistry 2014.0
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode
Journal of Medicinal Chemistry 2016.0
Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities
European Journal of Medicinal Chemistry 2018.0
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer’s Disease Mouse Model
Journal of Medicinal Chemistry 2021.0
Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model
RSC Medicinal Chemistry 2022.0
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine
European Journal of Medicinal Chemistry 2014.0
Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors
Bioorganic & Medicinal Chemistry 2018.0
N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents
European Journal of Medicinal Chemistry 2020.0
Isosorbide-2-carbamate Esters: Potent and Selective Butyrylcholinesterase Inhibitors
Journal of Medicinal Chemistry 2008.0